[Pubmed] Correction to: Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use
Posté : 17 avr. 2023 12:00
CNS Drugs. 2023 Apr 17. doi: 10.1007/s40263-023-01003-w. Online ahead of print.
NO ABSTRACT
PMID:37067655 | DOI:10.1007/s40263-023-01003-w
Source: https://pubmed.ncbi.nlm.nih.gov/3706765 ... t6+86293ac